The launch of opicapone for Parkinson’s disease: negatives versus positives

Ana Castro Caldas, Tiago Teodoro, Joaquim J Ferreira
  • Expert Opinion on Drug Safety, February 2018, Taylor & Francis
  • DOI: 10.1080/14740338.2018.1433659
The author haven't finished explaining this publicationThe author haven't finished explaining this publication

The following have contributed to this page: Joaquim Ferreira

In partnership with: